Pheno Therapeutics
- Biotech or pharma, therapeutic R&D
Developing remyelination therapeutics to treat demyelinating diseases and diseases characterised by myelin deficits. Initial focus on MS.
June 16-19, 2025
Boston Convention & Exhibition Center
Developing remyelination therapeutics to treat demyelinating diseases and diseases characterised by myelin deficits. Initial focus on MS.